Evaluate LAE102 in Healthy and Overweight/Obese Subjects
Status:
RECRUITING
Trial end date:
2026-02-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of LAE102 injection in healthy and overweight/obese participants, and also evaluate the preliminary pharmacodynamic effect of multiple dose injections in overweight/obese participants.